Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) was the recipient of a significant increase in short interest during the month of March. As of March 13th, there was short interest totaling 1,841,462 shares, an increase of 111.0% from the February 26th total of 872,774 shares. Currently, 2.9% of the company’s stock are short sold. Based on an average daily volume of 2,110,901 shares, the days-to-cover ratio is presently 0.9 days.

Bioceres Crop Solutions Price Performance

Shares of Bioceres Crop Solutions stock opened at $0.39 on Friday. The company’s fifty day simple moving average is $0.65 and its two-hundred day simple moving average is $1.27. Bioceres Crop Solutions has a 12-month low of $0.35 and a 12-month high of $5.18. The firm has a market cap of $24.72 million, a PE ratio of -0.11 and a beta of 0.53. The company has a quick ratio of 0.69, a current ratio of 0.90 and a debt-to-equity ratio of 0.32.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its earnings results on Friday, March 13th. The company reported ($0.08) earnings per share for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.15). Bioceres Crop Solutions had a negative return on equity of 22.43% and a negative net margin of 82.83%.The firm had revenue of $73.67 million for the quarter, compared to analysts’ expectations of $104.55 million. As a group, equities analysts expect that Bioceres Crop Solutions will post -0.05 EPS for the current year.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Invesco Ltd. bought a new position in shares of Bioceres Crop Solutions in the 4th quarter worth about $45,000. Ardsley Advisory Partners LP boosted its holdings in Bioceres Crop Solutions by 691.7% in the fourth quarter. Ardsley Advisory Partners LP now owns 475,000 shares of the company’s stock worth $622,000 after acquiring an additional 415,000 shares in the last quarter. GAM Holding AG purchased a new stake in shares of Bioceres Crop Solutions in the fourth quarter worth $655,000. State of Wisconsin Investment Board bought a new position in shares of Bioceres Crop Solutions during the fourth quarter valued at $247,000. Finally, Marshall Wace LLP increased its holdings in shares of Bioceres Crop Solutions by 180.0% during the fourth quarter. Marshall Wace LLP now owns 595,410 shares of the company’s stock valued at $780,000 after acquiring an additional 382,744 shares in the last quarter. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Analyst Upgrades and Downgrades

BIOX has been the subject of a number of recent analyst reports. Canaccord Genuity Group reduced their price objective on shares of Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a research report on Friday, January 2nd. Weiss Ratings reissued a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $4.00.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.